Admedus is a global provider in medical devices and technologies that provides solutions to healthcare groups. We are focused on developing, commercialising and distributing next generation innovative technologies. Our investment in world-class research and partnership with renowned medical leaders, uniquely position us to provide end-to-end medical solutions.
At Admedus, we specialise in tissue engineering, are developing a suite of bio-compatible implants for repair and reconstruction of defective or damaged tissue in human body and delivers a range of medical products, technologies and infusion solutions that can make a difference to the outcomes and quality of patients lives.
Our ADAPT and Infusion products are available in specific regions.
With our ADAPT portfolio:
CardioCel® is approved/cleared for sale in Europe, the US, Canada, Hong Kong, Malaysia, Singapore, New Zealand and Middle East and North Africa Region. CardioCel® is also available under the special access scheme in Australia and other select countries.
CardioCel® is currently used by leading heart centres around the world and has been implanted in thousands of patients to date.
VascuCel® is approved/cleared for sale in the US only. For more information on VascuCel, please contact us here.
Currently Admedus Infusion products are only available for purchase in Australia and New Zealand.
Interested to know more of our Products and Services, click here and choose the correct region to contact us.